Co-infection and Cancer (R01 Clinical Trial Not Allowed)
National Institutes of Health (NIH)
No specified funding ceiling or floor.
Project period may not exceed 5 years.
Enhance mechanistic and epidemiologic understanding of infection-related cancers.
Focus on the roles of co-infection in cancer development.
Researchers in cancer and infectious diseases.
Understudied populations affected by infection-related cancers.
Eligible organization types include higher education institutions, nonprofits, for-profit organizations, local and state governments, and federal agencies.
Nonprofits with and without 501(c)(3) IRS status are eligible.
Open to U.S. and non-domestic (foreign) entities.
U.S.-based applicants are encouraged to engage in international partnerships.
Focus on mechanistic and epidemiologic investigations of co-infection and cancer.
Studies should exclude co-infection with HIV and focus on known oncogenic agents.
Application budgets are not limited but must reflect the actual needs of the proposed project.
Application due date is January 7, 2026.
Opening date for submissions is January 5, 2025.
No restrictions on prior grant funding mentioned.
Follow the instructions in the Research (R) Instructions in the How to Apply - Application Guide.
Applications will be evaluated based on scientific and technical merit.
Applications will undergo peer review and may receive a second level of review by the Advisory Council.
Scientific and technical merit, availability of funds, and relevance to program priorities will be considered.
Preference for studies that investigate co-infections in diverse populations.
Applications focusing solely on co-infection with HIV will not be reviewed.
Encouragement for equitable international partnerships.
Broad examination of co-infection in cancer susceptibility may provide significant insights.
Strong preliminary data supporting the proposed research.
Submitting applications that do not comply with the application instructions.
Engage with diverse populations and consider international collaborations.
Highlight unique aspects of the proposed research that address significant gaps in knowledge.